Biomm S.A. (BOVESPA: BIOM3)
Health Care · Biotechnology · BR
R$6.45
+5.22% today · -36.2% 1Y
Biomm S.A. (BOVESPA: BIOM3) operates in the Biotechnology industry within the Health Care sector. The company is valued at $168.63M and employs 130 people.
Over the last twelve months the share price has lost 36.2%, trading between 4.82 and 10.39.
Tweenvest scores Biomm S.A. across four factors: quality 37/100, value 44/100, growth 100/100. Its strongest factor is growth.
BIOM3 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $168.63M
- Revenue (TTM)
- $74.20M
- P/E
- 29.13
- EPS
- 0.22
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- R$10.39
- 52-week low
- R$4.82
- Avg volume (3M)
- —
- Shares outstanding
- 136.85M
- Employees
- 130
- Next earnings
- —
About Biomm S.A.
Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product portfolio features pharmaceutical and healthcare solutions, including AFREZZA, a human insulin administered as an inhalation powder, and GLARGILIN, a type of glargine insulin. The company also supplies HERZUMA, a trastuzumab, and CONFORT CARE, a moisturizing foot cream. Biomm S.A. was established in 2001 and maintains its headquarters in São Paulo, Brazil.
- ISIN
- BRBIOMACNOR2
- Founded
- 2001
- Listed since
- Jan 11, 2000
- Exchange
- Bolsa de Valores de Sao Paulo
- Currency
- BRL
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dx & Vx Co., Ltd.KOSDAQ: A180400 | $172.85M | ₩2,365.00 | -0.84% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $172.51M | $6.43 | +2.88% |
| Innovacell Inc.TSE: 504A | $172.34M | ¥602.00 | +3.97% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $171.38M | $15.20 | -6.46% |
| curacle co.,ltd.KOSDAQ: A365270 | $167.81M | ₩10,200.00 | +6.58% |
| PepGen Inc.NasdaqGS: PEPG | $166.22M | $2.38 | -0.83% |
| Organogenesis Holdings Inc.NasdaqCM: ORGO | $164.70M | $1.28 | -3.03% |
| Bioneer CorporationKOSDAQ: A064550 | $164.24M | ₩8,570.00 | +4.77% |
Figures last refreshed Oct 4, 2026.